Overview

A CA 125 test measures the amount of the protein cancer antigen 125 in the blood. Cancer antigen 125 also is called CA 125.

This test may be used to monitor certain cancers during and after treatment. In some situations, the test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease.

A CA 125 test isn't accurate enough to use for ovarian cancer screening in general because many conditions can increase the level of this protein.

Conditions that can cause an increase in CA 125 include many that aren't cancerous, such as menstruation and uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal and fallopian tube cancers.

Why it's done

A CA 125 test measures the amount of cancer antigen 125 in the blood. A healthcare professional might use it for several reasons:

  • To monitor cancer treatment. If you have ovarian, endometrial, peritoneal or fallopian tube cancer, your healthcare professional may recommend a CA 125 test on a regular basis to monitor your condition and treatment.

    But such monitoring hasn't been shown to improve the outcome for those with ovarian cancer, and it might lead to additional and unnecessary rounds of chemotherapy or other treatments.

  • To screen for ovarian cancer if you're at high risk. If you have a strong family history of ovarian cancer or you have an inherited gene that increases the risk of ovarian cancer, your healthcare professional may recommend a CA 125 test as one way to screen for this cancer.

    Some healthcare professionals may recommend CA 125 testing combined with transvaginal ultrasound every 6 to 12 months for those at very high risk.

    However, some people with ovarian cancer may not have an increased CA 125 level. And no evidence shows that this screening decreases the chance of dying of ovarian cancer. An elevated level of CA 125 could prompt your healthcare professional to put you through unnecessary and possibly harmful tests.

  • To check for cancer recurrence. Rising CA 125 levels may indicate that ovarian cancer has come back after treatment. Regular monitoring of CA 125 has not been shown to improve outcomes for those with ovarian cancer and may lead to additional and unnecessary rounds of chemotherapy or other treatments.

If your healthcare professional suspects that you may have ovarian cancer or another type of cancer, you may undergo additional tests. Other tests that may be helpful in evaluating these cancers include a transvaginal or pelvic ultrasound, serum human epididymis protein 4 (HE4), CT, and MRI. A procedure to remove a sample of cells for testing may be needed to confirm the diagnosis.

From Mayo Clinic to your inbox

Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing health. Click here for an email preview.

We use the data you provide to deliver you the content you requested. To provide you with the most relevant and helpful information, we may combine your email and website data with other information we have about you. If you are a Mayo Clinic patient, we will only use your protected health information as outlined in our Notice of Privacy Practices. You may opt out of email communications at any time by clicking on the unsubscribe link in the email.

Risks

A CA 125 test measures the amount of cancer antigen 125 in a sample of blood. The risks of having a blood sample taken are small. Risks can include bleeding and feeling lightheaded. Rarely, an infection can happen after a blood sample is taken.

How you prepare

A CA 125 test measures the amount of cancer antigen 125 in the blood. You typically don't need to do anything to prepare. If your blood is being tested only for CA 125, you can eat and drink as usual before the test.

What you can expect

A CA 125 test measures the amount of cancer antigen 125 in the blood. For a CA 125 test, a member of your healthcare team takes a sample of blood by inserting a needle into a vein, usually in the hand or arm. The blood sample is sent to a lab for analysis. You can return to your usual activities immediately.

Results

A CA 125 test measures the amount of cancer antigen 125 in the blood. The results are given to your healthcare professional, who will discuss the results with you. Ask your healthcare professional when you can expect to know your results.

If your CA 125 level is higher than expected, you may have a condition that isn't cancerous, or the test result could mean that you have ovarian, endometrial, peritoneal or fallopian tube cancer. Your healthcare professional may recommend other tests and procedures to determine your diagnosis.

If you've been diagnosed with ovarian, endometrial, peritoneal or fallopian tube cancer, a decreasing CA 125 level often indicates that the cancer is responding to treatment. A rising level may indicate a return or continued growth of the cancer.

A number of conditions that aren't cancerous can cause an elevated CA 125 level, including:

  • Endometriosis.
  • Liver disease.
  • Menstruation.
  • Pelvic inflammatory disease.
  • Pregnancy.
  • Uterine fibroids.
March 07, 2025
  1. CA-125. Testing.com. https://www.testing.com/tests/ca-125/. Accessed Dec. 14, 2021.
  2. CA 125 levels: Your guide. Foundation for Women's Cancer. https://www.foundationforwomenscancer.org/gynecologic-cancers/cancer-types/ovarian/. Accessed Dec. 17, 2021.
  3. Tumor markers. National Cancer Institute. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet. Accessed Dec. 14, 2021.
  4. Cancer antigen 125 (CA 125), serum. Mayo Clinical Laboratories. https://www.mayocliniclabs.com/test-catalog/overview/9289#Clinical-and-Interpretive. Accessed Dec. 14, 2021.
  5. Ovarian, fallopian tube, and primary peritoneal cancer screening (PDQ) – Patient version. National Cancer Institute. https://www.cancer.gov/types/ovarian/patient/ovarian-screening-pdq#section/all. Accessed Dec. 14, 2021.
  6. Zhang M, et al. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. BBA – Reviews on Cancer. 2021; doi:10.1016/j.bbcan.2021.188503.
  7. Duska LR. Approach to survivors of epithelial ovarian, fallopian tubal, or peritoneal carcinoma. https://www.uptodate.com/contents/search. Accessed Dec. 14, 2021.
  8. Genetic/familial high-risk assessment: Breast and ovarian. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1503. Accessed Sept. 7, 2021.
  9. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1453. Accessed Sept. 7, 2021.
  10. AskMayoExpert. Screening and risk reduction for ovarian cancer. Mayo Clinic; 2021.

Related

News from Mayo Clinic

Products & Services